Also found in: Medical, Wikipedia.
MIRACLMyocardial Ischemia Reduction with Aggressive Cholesterol Lowering
MIRACLMid-Infrared Advanced Chemical Laser
References in periodicals archive ?
Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.
[4] Nonstandard abbreviations: VLDL, very-low-density lipoprotein; IDL, intermediate-density lipoprotein; CIHDS, Copenhagen Ischemic Heart Disease Study; HR, hazard ratio; MIRACL, Myocardial Ischemia Reduction with Acute Cholesterol Lowering; EVOLVE, Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events.
SPA7D AY AY D MI MIRACL RACL I E L O I L BALM BALM, [euro]10 [euro]10 BIO IO IO B D O E RM RMA SENSIBIO ENSIBIO S AR ARBB BB BB R SP S F30, F30, P [euro]1775 [euro]17.75 [euro]17.75 Sunshine can make some skins blotchy and sensitised, which is where this first-ever anti-redness BB comes in.
In 1985, a deuterium fluoride laser known as the Mid-Infrared Advanced Chemical Laser (MIRACL) was conceived.
We evaluate the cryptographic operations by using of MIRACL (version 5.6.1, [17]), a standard cryptographic library, on a laptop using the Intel Core i5-2400 at a frequency of 3.10 GHz with 3 GB memory, and then obtain the average running time in Table 2.
Therapeutic benefits of sCD40L were also seen in MIRACL Study wherein patients with acute coronary syndromes and high sCD40L had a significant reduction in the risk of recurrent cardiovascular events with early statin therapy (36).
MIRACL RACLE BELL LL SOU OUND NDS My favourite My s y favourite ong Who knew g 8.
Other statin trials in the early 2000's (MIRACL, HPS, PROSPER ALLHAT LLT, ASCOT, CARDS, ALLIANCE, PROVE IT, A to Z) focus on high-risk groups (ACS, elderly, diabetes, hypertension) and comparisons beyond placebo: versus usual care (ALLIANCE, ALLHATLLT) or active comparator (PROVE IT, A to Z).
A recent post hoc analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial compared the benefits of atorvastatin 80 mg in older ([greater than or equal to] 65 years, mean age 74 +/- 6 years) and younger (<65 years) patients with ACS.
And that trial has been convincingly supported by a second study, the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) trial.